Literature DB >> 11564287

Genistein, a soybean isoflavone, inhibits inward rectifier K(+) channels in rat osteoclasts.

F Okamoto1, K Okabe, H Kajiya.   

Abstract

Genistein, a soybean-derived isoflavone with an inhibitory effect on protein tyrosine kinases (PTKs), has been shown to suppress osteoclastic bone resorption. To clarify the mechanisms underlying this action, we investigated the effects of genistein on inward rectifier K(+) current (I(Kir)) in rat osteoclasts by using the whole-cell patch-clamp technique. Extracellularly applied genistein inhibited I(Kir) in a concentration-dependent manner. Physiologically attainable concentrations of genistein inhibited I(Kir). IC(50) values obtained 5 and 10 min after the application of genistein were 54 and 27 microM, respectively. The removal of genistein partially restored the current. Daidzein, an isoflavone without PTK-inhibiting activity, also showed a weak inhibitory effect on I(Kir), but genistin had no effect. Other PTK inhibitors, tyrphostin A25, tyrphostin B42, and tyrphostin B46, inhibited I(Kir), whereas herbimycin A and lavendustin A were without effect. The inactive tyrphostin, A1, showed a similar inhibitory effect as tyrphostin A25. The tyrosine phosphatase inhibitor, orthovanadate, did not affect the inhibitory potency of genistein on I(Kir). The inhibitory action of genistein was unaffected by changing intracellular Ca(2+) concentration ([Ca(2+)]i) or by pretreatment of the cell with GDPbetaS, Rp-cAMPS, okadaic acid, or staurosporine. Therefore the inhibition of I(Kir) by genistein does not depend on PTK inhibition, involvement of changes in [Ca(2+)]i, or secondary interaction with protein kinase A or protein kinase C. Genistein-induced inhibition of I(Kir) would cause membrane depolarization, elevation of [Ca(2+)]i, and inhibition of osteoclastic bone resorption.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11564287     DOI: 10.2170/jjphysiol.51.501

Source DB:  PubMed          Journal:  Jpn J Physiol        ISSN: 0021-521X


  10 in total

1.  Phytoestrogens: food or drug?

Authors:  Lucia Bacciottini; Alberto Falchetti; Barbara Pampaloni; Elisa Bartolini; Anna Maria Carossino; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2007-05

2.  Five-year follow-up study of a kidney-tonifying herbal Fufang for prevention of postmenopausal osteoporosis and fragility fractures.

Authors:  Wei-Min Deng; Peng Zhang; Hai Huang; You-Gao Shen; Qin-Hua Yang; Wei-Li Cui; Yang-Shu He; Song Wei; Zhu Ye; Fang Liu; Ling Qin
Journal:  J Bone Miner Metab       Date:  2012-06-22       Impact factor: 2.626

Review 3.  Side-effects of protein kinase inhibitors on ion channels.

Authors:  Youn Kyoung Son; Hongzoo Park; Amy L Firth; Won Sun Park
Journal:  J Biosci       Date:  2013-12       Impact factor: 1.826

4.  Effects of different doses of ferutinin on bone formation/resorption in ovariectomized rats.

Authors:  Francesco Cavani; Marzia Ferretti; Gianluca Carnevale; Laura Bertoni; Manuela Zavatti; Carla Palumbo
Journal:  J Bone Miner Metab       Date:  2012-07-25       Impact factor: 2.626

5.  Molecular basis for genistein-induced inhibition of Kir2.3 currents.

Authors:  Zhiying Zhao; Boyi Liu; Guohong Zhang; Zhanfeng Jia; Qingzhong Jia; Xian Geng; Hailin Zhang
Journal:  Pflugers Arch       Date:  2007-12-18       Impact factor: 3.657

Review 6.  Molecular signaling mechanisms behind polyphenol-induced bone anabolism.

Authors:  Elisa Torre
Journal:  Phytochem Rev       Date:  2017-08-31       Impact factor: 5.374

Review 7.  The protective activity of genistein against bone and cartilage diseases.

Authors:  Zhenyu Wu; Luying Liu
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

8.  Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol.

Authors:  A Bitto; B P Burnett; F Polito; H Marini; R M Levy; M A Armbruster; L Minutoli; V Di Stefano; N Irrera; S Antoci; R Granese; F Squadrito; D Altavilla
Journal:  Br J Pharmacol       Date:  2008-08-11       Impact factor: 8.739

9.  Progress in nanotechnology based approaches to enhance the potential of chemopreventive agents.

Authors:  Irfana Muqbil; Ashiq Masood; Fazlul H Sarkar; Ramzi M Mohammad; Asfar S Azmi
Journal:  Cancers (Basel)       Date:  2011-01-21       Impact factor: 6.639

10.  Epidermal growth factor receptor down-regulation triggers human myoblast differentiation.

Authors:  Marina C Leroy; Julie Perroud; Basile Darbellay; Laurent Bernheim; Stephane Konig
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.